<li>acetaminophen iv<p>acetaminophen iv increases effects of warfarin by unknown mechanism. Minor/Significance Unknown.</p></li><li>acetaminophen rectal<p>acetaminophen rectal increases effects of warfarin by unknown mechanism. Minor/Significance Unknown.</p></li><li>alprostadil intracavernous/urethral<p>alprostadil intracavernous/urethral increases effects of warfarin by pharmacodynamic synergism. Minor/Significance Unknown.</p></li><li>amobarbital<p>amobarbital will decrease the level or effect of warfarin by  affecting hepatic enzyme CYP2C19 metabolism. Minor/Significance Unknown.</p></li><li>armodafinil<p>armodafinil will increase the level or effect of warfarin by  affecting hepatic enzyme CYP2C19 metabolism. Minor/Significance Unknown.</p></li><li>ascorbic acid<p>ascorbic acid decreases effects of warfarin by pharmacodynamic antagonism. Minor/Significance Unknown. Dose &gt;10 g/day vitamin C.</p></li><li>butabarbital<p>butabarbital will decrease the level or effect of warfarin by  affecting hepatic enzyme CYP2C19 metabolism. Minor/Significance Unknown.</p></li><li>butalbital<p>butalbital will decrease the level or effect of warfarin by  affecting hepatic enzyme CYP2C19 metabolism. Minor/Significance Unknown.</p></li><li>ceftaroline<p>ceftaroline increases effects of warfarin by Other (see comment). Minor/Significance Unknown. 
Comment: Cephalosporins with a methylthiotetrazole (MTT) side ring (eg, cefotetan, cefoperazone) are more frequently associated with hypoprothrombinemic activity.</p></li><li>chlorella<p>chlorella decreases effects of warfarin by pharmacodynamic antagonism. Minor/Significance Unknown. Theoretical, due to vitamin K content.</p></li><li>coenzyme q10<p>coenzyme q10 decreases effects of warfarin by pharmacodynamic antagonism. Minor/Significance Unknown.</p></li><li>colestipol<p>colestipol decreases levels of warfarin by inhibition of GI absorption. Applies only to oral form of both agents. Minor/Significance Unknown.</p></li><li>cranberry<p>cranberry increases effects of warfarin by unknown mechanism. Minor/Significance Unknown. Theoretical interaction, based on case reports.  Cranberry may inhibit cytochrome P450 2C9.</p></li><li>demeclocycline<p>demeclocycline increases effects of warfarin by pharmacodynamic synergism. Minor/Significance Unknown.</p></li><li>dexmethylphenidate<p>dexmethylphenidate increases effects of warfarin by decreasing metabolism. Minor/Significance Unknown.</p></li><li>dimenhydrinate<p>dimenhydrinate increases effects of warfarin by unknown mechanism. Minor/Significance Unknown.</p></li><li>doxycycline<p>doxycycline increases effects of warfarin by pharmacodynamic synergism. Minor/Significance Unknown.</p></li><li>efavirenz<p>efavirenz will increase the level or effect of warfarin by  affecting hepatic enzyme CYP2C19 metabolism. Minor/Significance Unknown.</p></li><li>esomeprazole<p>esomeprazole will increase the level or effect of warfarin by  affecting hepatic enzyme CYP2C19 metabolism. Minor/Significance Unknown.</p></li><li>etravirine<p>etravirine will increase the level or effect of warfarin by  affecting hepatic enzyme CYP2C19 metabolism. Minor/Significance Unknown.</p></li><li>felbamate<p>felbamate will increase the level or effect of warfarin by  affecting hepatic enzyme CYP2C19 metabolism. Minor/Significance Unknown.</p></li><li>felodipine<p>felodipine will increase the level or effect of warfarin by  affecting hepatic enzyme CYP2C19 metabolism. Minor/Significance Unknown.</p></li><li>fluconazole<p>fluconazole will increase the level or effect of warfarin by  affecting hepatic enzyme CYP2C19 metabolism. Minor/Significance Unknown.</p></li><li>glyburide<p>glyburide increases effects of warfarin by unspecified interaction mechanism. Minor/Significance Unknown.</p></li><li>hexobarbital<p>hexobarbital will decrease the level or effect of warfarin by  affecting hepatic enzyme CYP2C19 metabolism. Minor/Significance Unknown.</p></li><li>horseradish<p>horseradish increases effects of warfarin by pharmacodynamic synergism. Minor/Significance Unknown. Theoretical interaction.</p></li><li>lymecycline<p>lymecycline increases effects of warfarin by pharmacodynamic synergism. Minor/Significance Unknown.</p></li><li>mephobarbital<p>mephobarbital will decrease the level or effect of warfarin by  affecting hepatic enzyme CYP2C19 metabolism. Minor/Significance Unknown.</p></li><li>metronidazole topical<p>metronidazole topical will increase the level or effect of warfarin by  decreasing metabolism. Minor/Significance Unknown. Oral metronidazole  potentiates the effect of warfarin; less likely to occur with topical administration because of low absorption</p></li><li>metronidazole vaginal<p>metronidazole vaginal will increase the level or effect of warfarin by  decreasing metabolism. Minor/Significance Unknown. Oral metronidazole  potentiates the effect of warfarin; less likely to occur with vaginal administration because of low absorption</p></li><li>mineral oil<p>mineral oil decreases levels of warfarin by inhibition of GI absorption. Applies only to oral form of both agents. Minor/Significance Unknown.</p></li><li>minocycline<p>minocycline increases effects of warfarin by pharmacodynamic synergism. Minor/Significance Unknown.</p></li><li>modafinil<p>modafinil will increase the level or effect of warfarin by  affecting hepatic enzyme CYP2C19 metabolism. Minor/Significance Unknown.</p></li><li>omeprazole<p>omeprazole will increase the level or effect of warfarin by  affecting hepatic enzyme CYP2C19 metabolism. Minor/Significance Unknown.</p></li><li>oxcarbazepine<p>oxcarbazepine will increase the level or effect of warfarin by  affecting hepatic enzyme CYP2C19 metabolism. Minor/Significance Unknown.</p></li><li>oxytetracycline<p>oxytetracycline increases effects of warfarin by pharmacodynamic synergism. Minor/Significance Unknown.</p></li><li>parecoxib<p>parecoxib will increase the level or effect of warfarin by  affecting hepatic enzyme CYP2C19 metabolism. Minor/Significance Unknown.</p></li><li>parsley<p>parsley increases effects of warfarin by pharmacodynamic synergism. Minor/Significance Unknown. Theoretical interaction.</p></li><li>pentobarbital<p>pentobarbital will decrease the level or effect of warfarin by  affecting hepatic enzyme CYP2C19 metabolism. Minor/Significance Unknown.</p></li><li>phenobarbital<p>phenobarbital will decrease the level or effect of warfarin by  affecting hepatic enzyme CYP2C19 metabolism. Minor/Significance Unknown.</p></li><li>primidone<p>primidone will decrease the level or effect of warfarin by  affecting hepatic enzyme CYP2C19 metabolism. Minor/Significance Unknown.</p></li><li>raloxifene<p>raloxifene increases effects of warfarin by plasma protein binding competition. Minor/Significance Unknown.</p></li><li>ribavirin<p>ribavirin decreases effects of warfarin by unknown mechanism. Minor/Significance Unknown. Case report.</p></li><li>rifampin<p>rifampin will decrease the level or effect of warfarin by  affecting hepatic enzyme CYP2C19 metabolism. Minor/Significance Unknown.</p></li><li>rose hips<p>rose hips decreases effects of warfarin by pharmacodynamic antagonism. Minor/Significance Unknown. Dose &gt;10 g/day vitamin C.</p></li><li>secobarbital<p>secobarbital will decrease the level or effect of warfarin by  affecting hepatic enzyme CYP2C19 metabolism. Minor/Significance Unknown.</p></li><li>sucralfate<p>sucralfate decreases levels of warfarin by inhibition of GI absorption. Applies only to oral form of both agents. Minor/Significance Unknown.</p></li><li>tetracycline<p>tetracycline increases effects of warfarin by pharmacodynamic synergism. Minor/Significance Unknown.</p></li><li>verteporfin<p>warfarin decreases effects of verteporfin by pharmacodynamic antagonism. Minor/Significance Unknown.</p></li><li>vitamin e<p>vitamin e, warfarin. Mechanism: pharmacodynamic synergism. Minor/Significance Unknown. Vitamin E at RDA does not change INR in pts. on chronic warfarin therapy; megadoses (~10x RDA) may enhance anticoagulant effects in vitamin K deficient pts.</p></li><li>voriconazole<p>voriconazole will increase the level or effect of warfarin by  affecting hepatic enzyme CYP2C19 metabolism. Minor/Significance Unknown.</p></li><li>watercress<p>watercress decreases effects of warfarin by pharmacodynamic antagonism. Minor/Significance Unknown. Theoretical interaction, due to high vitamin K content of watercress.</p></li>